CAN-ASC is a Canada-wide consortium of researchers and clinician scientists. We collaborate with international networks from academia and industry to develop consensus-driven, standardized and validated operating procedures (SOPs) for human immunology research.
The Canucks for Kids Fund Childhood Diabetes Laboratories aim to improve the lives of children with diabetes by advancing knowledge of type 1 and type 2 diabetes, through innovative and multi-disciplinary basic and clinical diabetes research.
For patients and families with unexplained health conditions, genome-wide sequencing can provide much-needed answers, but it can also raise a lot of questions. We are trying to figure out the best ways to provide genetic counselling for genome-wide sequencing in Canada so that we can best support these families. We will be looking into different clinical, ethical, and economic methods to make sure there is equitable access to genetic counselling and testing for all Canadians.
Researchers with the Michael Cuccione Childhood Cancer Research Program embrace one goal: to save children’s lives, while improving their health and quality of life through every phase of treatment and recovery.
BC Children’s Hospital houses the only Sleep Laboratory in the province of BC, where a multidisciplinary team provides diagnostic assessment and treatment for children and youth across BC, and conducts research to advance sleep medicine.
The BCCHR Trainee Omics Group is a team of enthusiastic trainees from across research themes at the BC Children's Research Institute who are eager to make bioinformatics accessible and fun for everyone!
A new study led by researchers from the BC Injury Research and Prevention Unit found girls in rural B.C. communities with poor access to local mental health services are at the highest risk of intentionally poisoning themselves. The most common substance used was non-opioid painkillers and the second most common substance used was medication for anxiety and depression.
Dr. Pascal Lavoie and his team compared the immune responses of babies to those of COVID-19-negative adults from Metro Vancouver. The antibody reactivity to SARS-CoV-2 in almost all of these adults was up to 100-fold higher compared to the infants at second blood sera collection. The researchers estimate that between 90-99 per cent of adults have positive antibody reactivity to SARS-CoV-2 antigens.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.